Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 6/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22803201 | 0.77 | PARP1 (0.33) | CYP1A2CYP3A4LMNAHPGDBLM | |
| SCHEMBL24823617 | 0.75 | EIF4A3 (0.36) | DAOPARP1 | |
| SCHEMBL1106174 | 0.72 | JAK2 (0.31) | PARP1 | |
| SCHEMBL765517 | 0.71 | — | — | |
| SCHEMBL24823773 | 0.71 | NOTUM (0.33) | KDM4EHSD17B10 | |
| SCHEMBL6181276 | 0.70 | — | — | |
| SCHEMBL830514 | 0.70 | DAO (0.46) | GABRA1GABRB1GABRB2CYP1A2CYP3A4 | |
| SCHEMBL6140775 | 0.69 | MAPT (0.43) | LMNAHPGDTSHRPARP1ALDH1A1 | |
| SCHEMBL2585105 | 0.69 | GABRA1 (0.68) | GABRA1GABRB1GABRB2CYP1A2CYP3A4 | |
| SCHEMBL29699645 | 0.69 | GABRA1 (0.68) | GABRA1GABRB1GABRB2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473764-A1 | METAL COMPLEXES | Hider, Robert Charles (GB) | 1992-03-11 | — | — | EP | claimed |
| WO-1991014664-A1 | METAL COMPLEXES | HIDER ROBERT CHARLES (GB) | 1991-10-03 | — | — | WO | claimed |
| EP-0094149-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING A COMPLEX OF IRON WITH N-SUBSTITUTED 3-HYDROXYPYRID-2-ONE OR -4-ONE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-09-10 | — | — | EP | claimed |
| US-11638764-B2 | Theranostic capture agents, compositions, and methods of using and making | INDI MOLECULAR, INC. (US) | 2023-05-02 | — | — | US | disclosed |
| US-11638764-B2 | Theranostic capture agents, compositions, and methods of using and making | INDI MOLECULAR, INC. (US) | 2023-05-02 | — | — | US | disclosed |
| US-20200147244-A1 | THERANOSTIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING | INDI MOLECULAR, INC. | 2020-05-14 | — | — | US | disclosed |
| EP-0473764-A1 | METAL COMPLEXES | Hider, Robert Charles (GB) | 1992-03-11 | — | — | EP | disclosed |
| WO-1991014664-A1 | METAL COMPLEXES | HIDER ROBERT CHARLES (GB) | 1991-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11638764-B2 | Theranostic capture agents, compositions, and methods of using and making | PSMA1, FOLH1, PSMA6 | GABRA1 3907/4885GABRB1 4190/4885GABRB2 4314/4885 |
| US-20200147244-A1 | THERANOSTIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING | PSMA1, FOLH1, PSMA6 | GABRA1 3907/4885GABRB1 4190/4885GABRB2 4314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.